Dr. Michael W. Compton, MD

Dr. Compton practices at Wake Ophthalmology Associates, PA in Cary, North Carolina.

Dr. Compton's NPI, 1184949554, was assigned on March 29, 2010. Dr. Compton graduated from UVA School of Medicine in 2010. Dr. Compton's North Carolina license number on file is NC2014-01307.

Dr. Compton's primary practice is Wake Ophthalmology Associates, PA, at 105 SW Cary Pkwy, Cary, NC 27511 in Wake County. The practice phone is (919) 467-4500.

Dr. Compton's primary practice is Wake Ophthalmology Associates, PA in Cary, North Carolina. Dmand AI also links Dr. Compton to 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Compton practices. Vendor and product names are available with a free account.

Ophthalmology is Dr. Compton's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Compton is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Compton's licenses on file in 2 states: North Carolina and Virginia.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, cold sores or genital herpes, conjunctivitis, dry eye, eye infection or inflammation and eyelid inflammation among the conditions Dr. Compton treats.

CMS data shows 1,733 Medicare services from Dr. Compton across 11 procedure codes in 2024, for 840 Medicare patients. Medicare paid $167,646 for them.

CMS counts 840 Medicare patients who saw Dr. Compton in 2024. The largest group is 65 to 74, with 371 patients. 75% of them have high cholesterol, and 66% have high blood pressure. 2% are also on Medicaid. Their average risk score is 0.89, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Compton's median patient age at 74, with 58% women.

In 2024, Dr. Compton wrote 1,019 Medicare Part D claims for 277 patients. 62% of them were for generic drugs. CMS names the drug for 916 of them, across 15 drugs with 11 or more claims each, at $172,437 in total drug cost. In 2023, CMS named 784 claims across 14 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Compton for performance year 2024, reported as part of a group. Dr. Compton accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 204 procedures of cataract surgery by Dr. Compton, more than 84% of the clinicians it reports for that procedure.

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 1 paper to Dr. Compton. Dr. Compton's most frequent co-authors are Andrew Richard Batchelet, MD and Ryan T. Scruggs, MD.

CMS Open Payments shows 61 general payments to Dr. Compton from 18 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 95% of the total. Alcon Laboratories Inc paid the most, $559.

Dr. Compton graduated from UVA School of Medicine in 2010.

Dr. Compton is in network with 17 carriers, including Elevance, Aetna and United Healthcare. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.